Hawaii 2024 Regular Session

Hawaii Senate Bill SCR64 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.C.R. NO. 64 THIRTY-SECOND LEGISLATURE, 2024 STATE OF HAWAII SENATE CONCURRENT RESOLUTION Urging the state AND counties TO PRIORITIZE AND DIRECT ALL AVAILABLE RESOURCES TO SUPPORTING COORDINATED INTERAGENCY COLLABORATION and public-private partnerships AIMED AT ADDRESSING the ongoing FENTANYL epidemic.
2	2
3	3	THE SENATE S.C.R. NO. 64
4	4	THIRTY-SECOND LEGISLATURE, 2024
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.C.R. NO.
10	10
11	11	64
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2024
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	SENATE CONCURRENT
30	30
31	31	RESOLUTION
32	32
33	33
34	34
35	35
36	36
37	37	Urging the state AND counties TO PRIORITIZE AND DIRECT ALL AVAILABLE RESOURCES TO SUPPORTING COORDINATED INTERAGENCY COLLABORATION and public-private partnerships AIMED AT ADDRESSING the ongoing FENTANYL epidemic.
38	38
39	39
40	40
41	41
42	42
43	43	WHEREAS; Hawaiʻi is experiencing an increasing record number of drug over-dose deaths; and WHEREAS, within this record number of overdose deaths, greater than thirty percent are caused by opioids, and the majority of the opioid overdose deaths were caused by opioids such as fentanyl; and WHEREAS, opioids are a class of drugs that act on the endorphin and pain receptors in the human brain, and which include prescription pain medications, as well as heroin and illicitly manufactured non-medical fentanyl; and WHEREAS, illicitly manufactured non-medical fentanyl is mixed into all known street drugs, including cannabis, and is pressed into fake look-alike pills, including fake oxytocin, Adderall, Xanax, and others; and WHEREAS, according to the CDC, fentanyl is up to fifty times stronger than heroin and one hundred times stronger than morphine, and, according to the United States Drug Enforcement Administration (DEA), a single two milligram dose, the equivalent of ten to fifteen grains of table salt, can be lethal; and WHEREAS, the mixing of fentanyl into other substances is a cause of unintentional fentanyl poisoning and overdose deaths in all age groups by persons unaware they are consuming fentanyl, including teens in the State who have been identified in the press and by family members; and WHEREAS, these overdose deaths from synthetic opioids represent an exponential increase since 2017; and WHEREAS, this rapid increase mirrors the trajectory of the fentanyl overdose crisis on the continental United States that began in 2013, and can reasonably be attributed to the arrival of fentanyl in the State; and WHEREAS, the availability and affordability of fentanyl contributes to its dramatically increasing use within the State. According to the DEA, fentanyl has a street price of less than $20 for a single dose; and WHEREAS, according to the Honolulu Emergency Services Department, currently three out of every ten overdose calls to emergency medical services involve fentanyl, and, according to the CDC, one person in the State dies of an overdose every twenty-eight hours; and WHEREAS, effective United States Food and Drug Administration-approved medications that treat opioid addition, including buprenorphine, naltrexone, and methadone, are available yet underutilized by Hawaiʻi's health providers, thus further increasing the risk of opioid overdoses and deaths; and WHEREAS, public health experts, including those at the CDC and the Substance Abuse and Mental Health Services Administration, recommend increasing access of naloxone hydrochloride, a pure opioid antagonist, to prevent death due to opioid overdose; and WHEREAS, studies have found that providing opioid overdose training and naloxone kits can help people identify signs of an opioid-related drug overdose and can help reduce opioid overdose mortality. Naloxone distribution programs also are endorsed by the American Medical Association as a best practice to prevent overdose-related injuries and deaths; and WHEREAS, the Legislature has a precedent of enacting laws that support expanded access to opioid antagonists and the role of registered pharmacists in the education, administration, dispensing, and prescription of opioid antagonists; and WHEREAS, the Legislature also recently passed Act 111, Session Laws of 2023, which decriminalizes fentanyl test strips, thus allowing people to easily detect contaminated drugs and avoid accidental and fatal drug overdoses; and WHEREAS, because unhealthy drug use is multifactorial, coordinated interagency collaboration and public-private partnerships are also necessary to effectively combat the opioid and fentanyl epidemic through various approaches, including but not limited to education and prevention; screening and early intervention; drug treatment, recovery support, and harm reduction services; and increased drug interdiction and law enforcement efforts; and WHEREAS, one example of an ongoing interagency collaboration is the Hawaiʻi Island Fentanyl Task Force, which was formed with the mission to reduce the demand and supply of illicit drugs in all age groups through the foregoing coordinated interagency approach; and WHEREAS, since its establishment, the Hawaiʻi Island Fentanyl Task Force has worked with national organizations, state and county agencies, nonprofit organizations, and numerous individuals to: (1) Produce public service announcements, print media, and social media awareness and educational campaigns regarding fentanyl; (2) Present over four hundred educational sessions in schools and to community groups; (3) Provide over twelve thousand Narcan kits to communities at dozens of pop-up events island wide; (4) Collaborate with the Hawaiʻi county police and fire departments to develop a drug addiction and overdose resource card for patrol police officers and emergency medical services first responders; and (5) Convene two Island-wide summits, one in 2022, and one in 2023, and a recent statewide stakeholder training on Fentanyl Task Force engagement and awareness; and WHEREAS, as evidenced by the accomplishments of the Hawaiʻi Island Fentanyl Task Force, interagency collaboration and public-private partnerships between the State, counties, and other stakeholders should be expanded to address the fentanyl epidemic on other islands as well; now, therefore, BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2024, the House of Representatives concurring, that the State and counties are urged to prioritize and direct all available resources to supporting coordinated interagency collaboration and public-private partnerships aimed at addressing the ongoing fentanyl epidemic; and BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to Hawaii's Congressional delegation; the Administrator of the centers for Medicare and Medicaid Services; Governor; Director of Health, who is requested to distribute copies of this concurrent resolution to all hospital medical directors and chief executive officers of hospitals and substance use disorder treatment and recovery programs operating in the State; Director of Human Services; Superintendent of Education; Director of Law Enforcement; State Public Defender; Chief Justice of the Hawaii Supreme Court; Insurance Commissioner, who is requested to distribute copies of this concurrent resolution to all health insurers in the State; Chairperson of the Hawaii Medical Board, who is requested to distribute copies of this concurrent resolution to all medical practitioners licensed in the State; and the Mayors, Chiefs of Police, and Prosecuting Attorneys of each county. OFFERED BY: _____________________________ Report Title: Interagency Collaboration; Public-Private Partnerships; State; Counties; Fentanyl Epidemic
44	44
45	45	WHEREAS; Hawaiʻi is experiencing an increasing record number of drug over-dose deaths; and
46	46
47	47
48	48
49	49	WHEREAS, within this record number of overdose deaths, greater than thirty percent are caused by opioids, and the majority of the opioid overdose deaths were caused by opioids such as fentanyl; and
50	50
51	51
52	52
53	53	WHEREAS, opioids are a class of drugs that act on the endorphin and pain receptors in the human brain, and which include prescription pain medications, as well as heroin and illicitly manufactured non-medical fentanyl; and
54	54
55	55
56	56
57	57	WHEREAS, illicitly manufactured non-medical fentanyl is mixed into all known street drugs, including cannabis, and is pressed into fake look-alike pills, including fake oxytocin, Adderall, Xanax, and others; and
58	58
59	59
60	60
61	61	WHEREAS, according to the CDC, fentanyl is up to fifty times stronger than heroin and one hundred times stronger than morphine, and, according to the United States Drug Enforcement Administration (DEA), a single two milligram dose, the equivalent of ten to fifteen grains of table salt, can be lethal; and
62	62
63	63
64	64
65	65	WHEREAS, the mixing of fentanyl into other substances is a cause of unintentional fentanyl poisoning and overdose deaths in all age groups by persons unaware they are consuming fentanyl, including teens in the State who have been identified in the press and by family members; and
66	66
67	67
68	68
69	69	WHEREAS, these overdose deaths from synthetic opioids represent an exponential increase since 2017; and
70	70
71	71
72	72
73	73	WHEREAS, this rapid increase mirrors the trajectory of the fentanyl overdose crisis on the continental United States that began in 2013, and can reasonably be attributed to the arrival of fentanyl in the State; and
74	74
75	75
76	76
77	77	WHEREAS, the availability and affordability of fentanyl contributes to its dramatically increasing use within the State. According to the DEA, fentanyl has a street price of less than $20 for a single dose; and
78	78
79	79
80	80
81	81	WHEREAS, according to the Honolulu Emergency Services Department, currently three out of every ten overdose calls to emergency medical services involve fentanyl, and, according to the CDC, one person in the State dies of an overdose every twenty-eight hours; and
82	82
83	83
84	84
85	85	WHEREAS, effective United States Food and Drug Administration-approved medications that treat opioid addition, including buprenorphine, naltrexone, and methadone, are available yet underutilized by Hawaiʻi's health providers, thus further increasing the risk of opioid overdoses and deaths; and
86	86
87	87
88	88
89	89	WHEREAS, public health experts, including those at the CDC and the Substance Abuse and Mental Health Services Administration, recommend increasing access of naloxone hydrochloride, a pure opioid antagonist, to prevent death due to opioid overdose; and
90	90
91	91
92	92
93	93	WHEREAS, studies have found that providing opioid overdose training and naloxone kits can help people identify signs of an opioid-related drug overdose and can help reduce opioid overdose mortality. Naloxone distribution programs also are endorsed by the American Medical Association as a best practice to prevent overdose-related injuries and deaths; and
94	94
95	95
96	96
97	97	WHEREAS, the Legislature has a precedent of enacting laws that support expanded access to opioid antagonists and the role of registered pharmacists in the education, administration, dispensing, and prescription of opioid antagonists; and
98	98
99	99
100	100
101	101	WHEREAS, the Legislature also recently passed Act 111, Session Laws of 2023, which decriminalizes fentanyl test strips, thus allowing people to easily detect contaminated drugs and avoid accidental and fatal drug overdoses; and
102	102
103	103
104	104
105	105	WHEREAS, because unhealthy drug use is multifactorial, coordinated interagency collaboration and public-private partnerships are also necessary to effectively combat the opioid and fentanyl epidemic through various approaches, including but not limited to education and prevention; screening and early intervention; drug treatment, recovery support, and harm reduction services; and increased drug interdiction and law enforcement efforts; and
106	106
107	107
108	108
109	109	WHEREAS, one example of an ongoing interagency collaboration is the Hawaiʻi Island Fentanyl Task Force, which was formed with the mission to reduce the demand and supply of illicit drugs in all age groups through the foregoing coordinated interagency approach; and
110	110
111	111
112	112
113	113	WHEREAS, since its establishment, the Hawaiʻi Island Fentanyl Task Force has worked with national organizations, state and county agencies, nonprofit organizations, and numerous individuals to:
114	114
115	115
116	116
117	117	(1) Produce public service announcements, print media, and social media awareness and educational campaigns regarding fentanyl;
118	118
119	119
120	120
121	121	(2) Present over four hundred educational sessions in schools and to community groups;
122	122
123	123
124	124
125	125	(3) Provide over twelve thousand Narcan kits to communities at dozens of pop-up events island wide;
126	126
127	127
128	128
129	129	(4) Collaborate with the Hawaiʻi county police and fire departments to develop a drug addiction and overdose resource card for patrol police officers and emergency medical services first responders; and
130	130
131	131
132	132
133	133	(5) Convene two Island-wide summits, one in 2022, and one in 2023, and a recent statewide stakeholder training on Fentanyl Task Force engagement and awareness; and
134	134
135	135
136	136
137	137	WHEREAS, as evidenced by the accomplishments of the Hawaiʻi Island Fentanyl Task Force, interagency collaboration and public-private partnerships between the State, counties, and other stakeholders should be expanded to address the fentanyl epidemic on other islands as well; now, therefore,
138	138
139	139
140	140
141	141	BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2024, the House of Representatives concurring, that the State and counties are urged to prioritize and direct all available resources to supporting coordinated interagency collaboration and public-private partnerships aimed at addressing the ongoing fentanyl epidemic; and
142	142
143	143
144	144
145	145	BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to Hawaii's Congressional delegation; the Administrator of the centers for Medicare and Medicaid Services; Governor; Director of Health, who is requested to distribute copies of this concurrent resolution to all hospital medical directors and chief executive officers of hospitals and substance use disorder treatment and recovery programs operating in the State; Director of Human Services; Superintendent of Education; Director of Law Enforcement; State Public Defender; Chief Justice of the Hawaii Supreme Court; Insurance Commissioner, who is requested to distribute copies of this concurrent resolution to all health insurers in the State; Chairperson of the Hawaii Medical Board, who is requested to distribute copies of this concurrent resolution to all medical practitioners licensed in the State; and the Mayors, Chiefs of Police, and Prosecuting Attorneys of each county.
146	146
147	147
148	148
149	149
150	150
151	151
152	152
153	153	OFFERED BY: _____________________________
154	154
155	155
156	156
157	157	OFFERED BY:
158	158
159	159	_____________________________
160	160
161	161
162	162
163	163
164	164
165	165
166	166
167	167
168	168
169	169
170	170
171	171
172	172
173	173
174	174
175	175
176	176
177	177
178	178
179	179
180	180
181	181
182	182
183	183
184	184
185	185
186	186
187	187
188	188
189	189	Report Title:
190	190
191	191	Interagency Collaboration; Public-Private Partnerships; State; Counties; Fentanyl Epidemic